Medacta Group SA (LON:0A05)

London flag London · Delayed Price · Currency is GBP · Price in CHF
148.80
-0.03 (-0.02%)
At close: Mar 27, 2026
Market Cap2.80B +28.5%
Revenue (ttm)596.55M +15.8%
Net Income83.28M +31.0%
EPS4.17 +31.0%
Shares Outn/a
PE Ratio33.61
Forward PE30.73
Dividend0.63 (0.43%)
Ex-Dividend DateMay 9, 2025
Volume3,009
Average Volume4,471
Open150.00
Previous Close148.83
Day's Range148.75 - 150.00
52-Week Range104.40 - 176.60
Beta1.15
RSI42.61
Earnings DateMar 13, 2026

About Medacta Group

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland. [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1958
Employees 2,036
Stock Exchange London Stock Exchange
Ticker Symbol 0A05

Financial Performance

In 2025, Medacta Group's revenue was 683.83 million, an increase of 15.79% compared to the previous year's 590.58 million. Earnings were 95.46 million, an increase of 30.97%.

Financial numbers in EUR Financial Statements

News

Medacta Group SA (XSWX:MOVE) Full Year 2025 Earnings Call Highlights: Robust Growth and ...

Medacta Group SA (XSWX:MOVE) Full Year 2025 Earnings Call Highlights: Robust Growth and Strategic Investments

16 days ago - GuruFocus

Full Year 2025 Medacta Group SA Earnings Call Transcript

Full Year 2025 Medacta Group SA Earnings Call Transcript

16 days ago - GuruFocus